Search

everythinglearnresearchcommunity

for

Search:↓

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

Tinea faciale can be mistaken for lupus due to similar symptoms.

Overt hyperthyroidism is the most common thyroid disorder, especially in women.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Telogen effluvium is a condition that causes temporary hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

Many COVID-19 survivors, especially women, experience hair loss and skin color changes, needing specific post-recovery care.

Doctors disagree on whether Raynaud phenomenon often leads to serious diseases, but agree that patients should be monitored for possible progression while being reassured. Rapid weight loss may cause hair loss.

Older age, certain hair loss conditions, and specific chemical levels increase the risk of hair loss after a transplant.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Starving yourself can cause hair loss, but stopping the diet can improve it.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Long-COVID has diverse, long-term health impacts, especially in young people.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Vitamin B12 deficiency can rarely cause excessive daytime sleepiness.

Gefitinib can cause rare scarring hair loss.

VKHD and sarcoidosis may share a common cause.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

The woman's hair loss is likely stress-related and should improve without treatment.